Latest News
Vistagen Therapeutics, Inc.
- Vistagen brings in GATC Health's predictive AI to design next trials of its neuroscience pipeline
- Vistagen partners with GATC Health on AI drug development By Investing.com
- Vistagen partners with GATC Health on AI drug development
- Vistagen Selects GATC Health to Apply Predictive AI Across Lead Clinical-Stage Drug Development Programs
- Vistagen Selects GATC Health to Apply Predictive AI Across Lead Clinical-Stage Drug Development Programs
- VistaGen Therapeutics Updates Executive Severance and Control Plan
- Dismissal without cause can qualify for severance at Vistagen (VTGN), even without a change in control.
- Vistagen (VTGN) Down -6.41% — Is the Sell-Off Overdone? 2026-10-05 - High Reward Trades
- Vistagen presents exploratory data on social anxiety treatment
- Vistagen Therapeutics Shares Positive Fasedienol Nasal Spray Data at Psych Congress 2026
Headlines from the last 30 days, linking to the original publishers. See all market news →